These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 22038920)
21. Epithelial-Myoepithelial Carcinoma: Frequent Morphologic and Molecular Evidence of Preexisting Pleomorphic Adenoma, Common HRAS Mutations in PLAG1-intact and HMGA2-intact Cases, and Occasional TP53, FBXW7, and SMARCB1 Alterations in High-grade Cases. El Hallani S; Udager AM; Bell D; Fonseca I; Thompson LDR; Assaad A; Agaimy A; Luvison AM; Miller C; Seethala RR; Chiosea S Am J Surg Pathol; 2018 Jan; 42(1):18-27. PubMed ID: 29135520 [TBL] [Abstract][Full Text] [Related]
22. Subsets of salivary duct carcinoma defined by morphologic evidence of pleomorphic adenoma, PLAG1 or HMGA2 rearrangements, and common genetic alterations. Chiosea SI; Thompson LD; Weinreb I; Bauman JE; Mahaffey AM; Miller C; Ferris RL; Gooding WE Cancer; 2016 Oct; 122(20):3136-3144. PubMed ID: 27379604 [TBL] [Abstract][Full Text] [Related]
23. EWSR1 rearrangement is present in a subset of myoepithelial tumors of salivary glands with variable morphology and does not correlate with clinical behavior. Ni H; Zhao PY; Wang XT; Xia QY; Wang X; Wu N; Shi SS; Li R; Yang WR; Ma HH; Zhou XJ; Rao Q Ann Diagn Pathol; 2017 Jun; 28():19-23. PubMed ID: 28648935 [TBL] [Abstract][Full Text] [Related]
24. Expanding the clinicopathological spectrum of TGFBR3-PLAG1 rearranged salivary gland neoplasms with myoepithelial differentiation including evidence of high-grade transformation. Rupp NJ; Höller S; Brada M; Vital D; Morand GB; Broglie MA; Huellner MW; Freiberger SN Genes Chromosomes Cancer; 2022 Feb; 61(2):94-104. PubMed ID: 34755406 [TBL] [Abstract][Full Text] [Related]
25. HMGA2-WIF1 Rearrangements Characterize a Distinctive Subset of Salivary Pleomorphic Adenomas With Prominent Trabecular (Canalicular Adenoma-like) Morphology. Agaimy A; Ihrler S; Baněčková M; Costés Martineau V; Mantsopoulos K; Hartmann A; Iro H; Stoehr R; Skálová A Am J Surg Pathol; 2022 Feb; 46(2):190-199. PubMed ID: 34324456 [TBL] [Abstract][Full Text] [Related]
26. Glial fibrillary acidic protein in tumor types with cartilaginous differentiation. Santos GC; Carvalho KC; Falzoni R; Simoes AC; Rocha RM; Lopes A; Vassallo J; Reis LF; Soares FA; da Cunha IW Mod Pathol; 2009 Oct; 22(10):1321-7. PubMed ID: 19668151 [TBL] [Abstract][Full Text] [Related]
27. Cutaneous syncytial myoepithelioma: clinicopathologic characterization in a series of 38 cases. Jo VY; Antonescu CR; Zhang L; Dal Cin P; Hornick JL; Fletcher CD Am J Surg Pathol; 2013 May; 37(5):710-8. PubMed ID: 23588365 [TBL] [Abstract][Full Text] [Related]
28. Aberrant PLAG1 expression in pleomorphic adenomas of the salivary gland: a molecular genetic and immunohistochemical study. Matsuyama A; Hisaoka M; Nagao Y; Hashimoto H Virchows Arch; 2011 May; 458(5):583-92. PubMed ID: 21394649 [TBL] [Abstract][Full Text] [Related]
29. Soft Tissue Special Issue: Myoepithelial Neoplasms of Soft Tissue: An Updated Review with Emphasis on Diagnostic Considerations in the Head and Neck. Jo VY Head Neck Pathol; 2020 Mar; 14(1):121-131. PubMed ID: 31950472 [TBL] [Abstract][Full Text] [Related]
30. PLAG1 immunohistochemistry is a sensitive marker for pleomorphic adenoma: a comparative study with PLAG1 genetic abnormalities. Katabi N; Xu B; Jungbluth AA; Zhang L; Shao SY; Lane J; Ghossein R; Antonescu CR Histopathology; 2018 Jan; 72(2):285-293. PubMed ID: 28796899 [TBL] [Abstract][Full Text] [Related]
31. PLAG1 expression in cutaneous mixed tumors: an immunohistochemical and molecular genetic study. Matsuyama A; Hisaoka M; Hashimoto H Virchows Arch; 2011 Nov; 459(5):539-45. PubMed ID: 21927843 [TBL] [Abstract][Full Text] [Related]
32. Clinicopathological effect of PLAG1 fusion genes in pleomorphic adenoma and carcinoma ex pleomorphic adenoma with special emphasis on histological features. Asahina M; Saito T; Hayashi T; Fukumura Y; Mitani K; Yao T Histopathology; 2019 Feb; 74(3):514-525. PubMed ID: 30307055 [TBL] [Abstract][Full Text] [Related]
33. Chromosomal rearrangements in PLAG1 of myoepithelial salivary gland tumours. Friedrich RE; Dilcher J; Jaehne M; Löning T Anticancer Res; 2012 May; 32(5):1977-81. PubMed ID: 22593475 [TBL] [Abstract][Full Text] [Related]
34. Adenomyoepitheliomas of the Breast Frequently Harbor Recurrent Hotspot Mutations in PIK3-AKT Pathway-related Genes and a Subset Show Genetic Similarity to Salivary Gland Epithelial-Myoepithelial Carcinoma. Lubin D; Toorens E; Zhang PJ; Jaffer S; Baraban E; Bleiweiss IJ; Nayak A Am J Surg Pathol; 2019 Jul; 43(7):1005-1013. PubMed ID: 31094929 [TBL] [Abstract][Full Text] [Related]
35. An analysis of PLAG1 and HMGA2 rearrangements in salivary duct carcinoma and examination of the role of precursor lesions. Bahrami A; Perez-Ordonez B; Dalton JD; Weinreb I Histopathology; 2013 Aug; 63(2):250-62. PubMed ID: 23738717 [TBL] [Abstract][Full Text] [Related]
36. Heterogeneity of PLAG1 gene rearrangements in pleomorphic adenoma. Kandasamy J; Smith A; Diaz S; Rose B; O'Brien C Cancer Genet Cytogenet; 2007 Aug; 177(1):1-5. PubMed ID: 17693184 [TBL] [Abstract][Full Text] [Related]
37. Recurrent rearrangements of the PLAG1 and HMGA2 genes in lacrimal gland pleomorphic adenoma and carcinoma ex pleomorphic adenoma. Andreasen S; von Holstein SL; Homøe P; Heegaard S Acta Ophthalmol; 2018 Nov; 96(7):e768-e771. PubMed ID: 29437290 [TBL] [Abstract][Full Text] [Related]
38. Salivary gland tumors in transgenic mice with targeted PLAG1 proto-oncogene overexpression. Declercq J; Van Dyck F; Braem CV; Van Valckenborgh IC; Voz M; Wassef M; Schoonjans L; Van Damme B; Fiette L; Van de Ven WJ Cancer Res; 2005 Jun; 65(11):4544-53. PubMed ID: 15930271 [TBL] [Abstract][Full Text] [Related]
39. Wnt pathway is involved in pleomorphic adenomas induced by overexpression of PLAG1 in transgenic mice. Zhao X; Ren W; Yang W; Wang Y; Kong H; Wang L; Yan L; Xu G; Fei J; Fu J; Zhang C; Wang Z Int J Cancer; 2006 Feb; 118(3):643-8. PubMed ID: 16108035 [TBL] [Abstract][Full Text] [Related]